Evidence map›Paper›PMID 40595813›Full record

ArticleScientific reports2025

Brain structural features with functional priori to classify Parkinson's disease and multiple system atrophy using diagnostic MRI.

Kai Zhou, Jie Li, Rui Huang, Jiali Yu, Rong Li, Wei Liao, Fengmei Lu, Xiaofei Hu, Huafu Chen, Qing Gao

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kai ZhouSchool of Mathematical Sciences, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 611731, P.R. China.
Jie LiSchool of Mathematical Sciences, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 611731, P.R. China.
Rui HuangDepartment of Neurology, Sichuan Provincial People's Hospital, Sichuan Academy of Medical Science, University of Electronic Science and Technology of China, Chengdu, China.
Jiali YuSchool of Mathematical Sciences, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 611731, P.R. China.
Rong LiThe Clinical Hospital of Chengdu Brain Science Institute, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, P.R. China.
Wei LiaoThe Clinical Hospital of Chengdu Brain Science Institute, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, P.R. China.
Fengmei LuSchool of Mathematical Sciences, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 611731, P.R. China. fengmei_lu@126.com.
Xiaofei HuThe Southwest Hospital, Third Military Medical University, Chongqing, 400038, P.R. China. jingminghou@hotmail.com.
Huafu ChenThe Clinical Hospital of Chengdu Brain Science Institute, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, P.R. China. chenhf@uestc.edu.cn.
Qing GaoSchool of Mathematical Sciences, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 611731, P.R. China. gaoqing@uestc.edu.cn.

Funding

National Key R&D Program of China 2022YFC2009906National Key Research and Development Program of China 62036003National Key Research and Development Program of China 82372085Youth Innovation Project of Sichuan Provincial Medical Association Q23078
6 · The paper itself

Abstract

Clinical two-dimensional (2D) MRI data has seen limited application in the early diagnosis of Parkinson's disease (PD) and multiple system atrophy (MSA) due to quality limitations, yet its diagnostic and therapeutic potential remains underexplored. This study presents a novel machine learning framework using reconstructed clinical images to accurately distinguish PD from MSA and identify disease-specific neuroimaging biomarkers. The structure constrained super-resolution network (SCSRN) algorithm was employed to reconstruct clinical 2D MRI data for 56 PD and 58 MSA patients. Features were derived from a functional template, and hierarchical SHAP-based feature selection improved model accuracy and interpretability. In the test set, the Extra Trees and logistic regression models based on the functional template demonstrated an improved accuracy rate of 95.65% and an AUC of 99%. The positive and negative impacts of various features predicting PD and MSA were clarified, with larger fourth ventricular and smaller brainstem volumes being most significant. The proposed framework provides new insights into the comprehensive utilization of clinical 2D MRI images to explore underlying neuroimaging biomarkers that can distinguish between PD and MSA, highlighting disease-specific alterations in brain morphology observed in these conditions.

Indexed as

BrainMagnetic Resonance ImagingMultiple System AtrophyParkinson DiseaseAgedAlgorithmsFemaleHumansMachine LearningMaleMiddle AgedNeuroimagingClassificationMachine learningMRIMultiple system atrophyParkinson’s disease

Identifiers

PMID40595813
PMCPMC12214848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.